Veterinary Medicines

Nobivac KC λυοφιλοποιημένο υλικό και διαλύτης για ρινικές σταγόνες, εναιώρημα για σκύλους

Authorised
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac KC λυοφιλοποιημένο υλικό και διαλύτης για ρινικές σταγόνες, εναιώρημα για σκύλους
Active substance:
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Nasal use
  • Nasal use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain B-C2, Live
    8.00
    log10 colony forming unit(s)
    /
    0.40
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Nasal spray, lyophilisate and solvent for suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Available in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 18747
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 18/03/2025
Download